Fierce Healthcare February 18, 2020
Express Scripts released its annual look at drug trend. Here’s the classes the PBM giant says are driving higher spending.
Drugs for inflammatory conditions drove nearly half of spending in commercial plans last year, a new report shows.
Express Scripts released its annual Drug Trend Report, which analyzes costs and spending for 33.6 million members enrolled in one of its drug plans.
The pharmacy benefit manager found that medications for inflammatory conditions such as psoriasis and rheumatoid arthritis drove 43.7% of spending, by far the highest among the different classes.
By comparison, diabetes and oncology drugs each contributed less than 20% of spend, the report shows.
Drugs for these conditions drove the largest portion of trend for...
Today's Sponsors
Today's Sponsor